Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page
- Check2 days agoChange DetectedRevision label changed from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Naples, Italy, 80131; removed Napoli, Italy, 80131; Revision: v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedStatus updated to Completed with new registry identifiers (UTN and EU CT) and the actual completion date added. New data-sharing links were added and outdated EngageZone links were removed.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now displays a revision tag updated to Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision 3.4.1 was added; the previous funding/operating-status notice associated with Revision 3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.